Please use this identifier to cite or link to this item:
https://dspace.iiti.ac.in/handle/123456789/10789
Title: | Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2 |
Authors: | Baig, Mirza Saqib;Rajpoot, Sajjan;Saqib, Uzma; |
Keywords: | catechin; coronavirus spike glycoprotein; dipeptidyl carboxypeptidase; epigallocatechin gallate; protein binding; spike protein, SARS-CoV-2; Caco-2 cell line; chemistry; drug therapy; human; metabolism; molecular docking; Angiotensin-Converting Enzyme 2; Caco-2 Cells; Catechin; COVID-19; Humans; Molecular Docking Simulation; Peptidyl-Dipeptidase A; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus |
Issue Date: | 2022 |
Publisher: | Public Library of Science |
Citation: | Ohishi, T., Hishiki, T., Baig, M. S., Rajpoot, S., Saqib, U., Takasaki, T., & Hara, Y. (2022). Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2. PLoS ONE, 17(7 July) doi:10.1371/journal.pone.0271112 |
Abstract: | The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds that could affect the fusion between the viral membrane (receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 spike protein) and the human cell receptor angiotensin-converting enzyme 2. Accordingly, we performed the enzyme-linked immunosorbent assay-based screening of 10 phytochemicals that already showed numerous positive effects on human health in several epidemiological studies and clinical trials. Among these phytochemicals, epigallocatechin gallate, a polyphenol and a major component of green tea, could effectively inhibit the interaction between the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 spike protein and the human cell receptor angiotensin-converting enzyme 2. Alternately, in silico molecular docking studies of epigallocatechin gallate and angiotensin-converting enzyme 2 indicated a binding score of −7.8 kcal/mol and identified a hydrogen bond between R393 and angiotensin-converting enzyme 2, which is considered as a key interacting residue involved in binding with the severe acute respiratory syndrome coronavirus 2 spike protein receptor-binding domain, suggesting the possible blocking of interaction between receptor-binding domain and angiotensin-converting enzyme 2. Furthermore, epigallocatechin gallate could attenuate severe acute respiratory syndrome coronavirus 2 infection and replication in Caco-2 cells. These results shed insight into identification and validation of severe acute respiratory syndrome coronavirus 2 entry inhibitors. © 2022 Ohishi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
URI: | https://doi.org/10.1371/journal.pone.0271112 https://dspace.iiti.ac.in/handle/123456789/10789 |
ISSN: | 1932-6203 |
Type of Material: | Journal Article |
Appears in Collections: | Department of Biosciences and Biomedical Engineering |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Altmetric Badge: